A detailed history of Wasatch Advisors Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 1,834,680 shares of NKTX stock, worth $4.75 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,834,680
Previous 1,392,555 31.75%
Holding current value
$4.75 Million
Previous $8.23 Million 0.75%
% of portfolio
0.04%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $2 Million - $3.54 Million
442,125 Added 31.75%
1,834,680 $8.29 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $1.18 Million - $2.42 Million
224,063 Added 19.18%
1,392,555 $8.23 Million
Q1 2024

Apr 18, 2024

SELL
$5.59 - $15.71 $5.21 Million - $14.6 Million
-931,207 Reduced 44.35%
1,168,492 $12.6 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $329,851 - $1.66 Million
251,795 Added 13.63%
2,099,699 $13.9 Million
Q3 2023

Nov 14, 2023

SELL
$1.39 - $2.29 $3.98 Million - $6.56 Million
-2,865,933 Reduced 60.8%
1,847,904 $2.57 Million
Q2 2023

Aug 07, 2023

BUY
$2.19 - $5.17 $1.75 Million - $4.14 Million
800,161 Added 20.45%
4,713,837 $10.3 Million
Q1 2023

May 12, 2023

BUY
$3.37 - $6.3 $3.97 Million - $7.43 Million
1,179,466 Added 43.14%
3,913,676 $13.9 Million
Q4 2022

Feb 14, 2023

BUY
$5.14 - $14.35 $4.18 Million - $11.7 Million
813,277 Added 42.34%
2,734,210 $16.4 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $3.55 Million - $5.31 Million
288,948 Added 17.71%
1,920,933 $25.3 Million
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $6.14 Million - $15.4 Million
789,683 Added 93.75%
1,631,985 $20.1 Million
Q1 2022

May 13, 2022

BUY
$8.66 - $14.99 $1.82 Million - $3.16 Million
210,700 Added 33.36%
842,302 $9.59 Million
Q4 2021

Feb 15, 2022

BUY
$12.79 - $26.88 $1.21 Million - $2.54 Million
94,678 Added 17.63%
631,602 $9.7 Million
Q3 2021

Nov 12, 2021

SELL
$26.67 - $38.76 $1.16 Million - $1.68 Million
-43,322 Reduced 7.47%
536,924 $14.9 Million
Q2 2021

Aug 12, 2021

BUY
$23.94 - $36.68 $1.46 Million - $2.24 Million
61,028 Added 11.75%
580,246 $18.4 Million
Q1 2021

May 10, 2021

BUY
$31.33 - $59.61 $2.91 Million - $5.53 Million
92,762 Added 21.75%
519,218 $17.1 Million
Q4 2020

Feb 12, 2021

SELL
$27.03 - $75.62 $4.28 Million - $12 Million
-158,363 Reduced 27.08%
426,456 $26.2 Million
Q3 2020

Nov 10, 2020

BUY
$23.52 - $47.9 $13.8 Million - $28 Million
584,819 New
584,819 $17.6 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $126M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.